About
Basilard BioTech develops Celletto™, a nanomechanical, non-viral gene delivery platform designed to enable scalable, cost-effective, and safer manufacturing of cell and gene therapies by delivering genes mechanically to cell nuclei without compromising cell viability.
Explore Basilard BioTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.